abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding abrdn Life Sciences Investors changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 76 | −2 |
| Shares | 9.10M | 10.4K | 9.62M | +530.4K (+5.8%) |
| Value | $124.0M | $142.2K | $136.4M | +$12.5M (+10.1%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sit Investment Associates Inc | 192,644 | $2.73M | 0.06% |
| Atlas Wealth LLC | 83,322 | $1.19M | 0.19% |
| Sanctuary Advisors, LLC | 11,901 | $154.4K | 0.00% |
| Independent Financial Group, LLC | 10,165 | $144.0K | 0.01% |
| IFP Advisors, Inc | 632 | $8.96K | 0.00% |
| WFA of San Diego, LLC | 300 | $4.25K | 0.00% |
| Atlas Capital Advisors LLC | 138 | $1.96K | 0.00% |
| Raleigh Capital Management Inc. | 104 | $1.47K | 0.00% |
Sold out (10)
Institutions that held abrdn Life Sciences Investors at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Lazard Asset Management LLC | 183,991 | $2.51M |
| Qube Research & Technologies Ltd | 38,293 | $521.9K |
| Matisse Capital | 34,333 | $468.0K |
| Two Sigma Investments, LP | 23,540 | $320.9K |
| Cerity Partners LLC | 15,608 | $212.7K |
| Wolverine Asset Management LLC | 14,929 | $203.5K |
| Logan Stone Capital, LLC | 14,778 | $201.4K |
| Cambridge Investment Research Advisors, Inc. | 10,927 | $149.0K |
| National Asset Management, Inc. | 11,500 | $143.4K |
| Future Financial Wealth Managment LLC | 2,000 | $27.3K |
Not filed for Q2 2024 yet (1)
Institutions that held abrdn Life Sciences Investors at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Eudaimonia Partners, LLC | 10,434 | $142.2K |